SLC6A3 and schizophrenia: Among the cognition and biological markers exhibiting alterations in schizophrenia, there were significant differences between the two groups in the relationships of DAT availability in left CN or putamen with attention scores and of plasma tyrosine level or the ratio of phenylalanine plus tyrosine to BCAA with executive function scores.